This is a preview of subscription content, log in via an institution to check access.
References
Malvezzi M, Santucci C, Boffetta P et al (2023) European cancer mortality predictions for the year 2023 with focus on lung cancer. Ann Oncol 34:410–419. https://doi.org/10.1016/j.annonc.2023.01.010
Aberle DR, Adams AM, Berg CD et al (2011) Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 365:395–409. https://doi.org/10.1056/NEJMoa1102873
de Koning HJ, van der Aalst CM, de Jong PA et al (2020) Reduced lung-cancer mortality with volume CT screening in a randomized trial. N Engl J Med 382:503–513. https://doi.org/10.1056/NEJMoa1911793
European Commission. Directorate-General for Health and Food Safety. Proposal for a Council Recommendation (CR) on strengthening prevention through early detection: a new approach on cancer screening replacing CR 2003/878/EC 2022. Brussels, 20-09-2022, EC. Available from: Proposal for a Council Recommendation (CR) on Strengthening prevention through early detection: a new approach on cancer screening replacing CR 2003/878/EC—European Commission (europa.eu) Accessed on 6 Oct 2024
Adams SJ, Stone E, Baldwin DR, Vliegenthart R, Lee P, Fintelmann FJ (2023) Lung cancer screening. Lancet 401:390–408. https://doi.org/10.1016/S0140-6736(22)01694-4
GBD 2021 Forecasting Collaborators (2021) Burden of disease scenarios for 204 countries and territories, 2022-2050: a forecasting analysis for the Global Burden of Disease Study 2021. Lancet 403:2204–2256. https://doi.org/10.1016/S0140-6736(24)00685-8
Spinnato P (2021) Low-dose computed tomography screening proposal for the “Big-3 Diseases”: lung cancer, chronic obstructive pulmonary disease, and cardiovascular disease. Acad Radiol 28:46–48. https://doi.org/10.1016/j.acra.2020.07.035
Kauczor HU, Baird AM, Blum TG et al (2020) European Society of Radiology (ESR) and the European Respiratory Society (ERS). ESR/ERS statement paper on lung cancer screening. Eur Radiol 30:3277–3294. https://doi.org/10.1007/s00330-020-06727-7
Behr C, Koffijberg H, IJzerman M et al (2024) Willingness to participate in combination screening for lung cancer, chronic obstructive pulmonary disease and cardiovascular disease in four European countries. Eur Radiol 34:4448–4456. https://doi.org/10.1007/s00330-023-10474-w
Gendarme S, Maitre B, Hanash S, Pairon JC, Canoui-Poitrine F, Chouaïd C (2024) Beyond lung cancer screening, an opportunity for early detection of COPD and cardiovascular diseases. JNCI Cancer Spectr 8:pkae082. https://doi.org/10.1093/jncics/pkae082
Funding
The authors state that this work has not received any funding.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Guarantor
The scientific guarantor of this publication is Sofia Ravara.
Conflict of interest
The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.
Statistics and biometry
No complex statistical methods were necessary for this paper.
Informed consent
Written informed consent was not required.
Ethical approval
Institutional Review Board approval was not required.
Study subjects or cohorts overlap
Not applicable.
Methodology
-
Commentary
Additional information
Publisher’s Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This comment refers to the article available at https://doi.org/10.1007/s00330-023-10474-w.
Rights and permissions
About this article
Cite this article
Ravara, S. Efficiency and cost-effectiveness of lung cancer screening: is combined screening of Big-3 diseases a major opportunity?. Eur Radiol (2024). https://doi.org/10.1007/s00330-024-11179-4
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1007/s00330-024-11179-4